Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors
- Fulya Koksalar Alkan,
- Hasan Korkaya(corresponding author)
- Istanbul Medipol University,
Scholary Output:
Contribution to journal
Article
Peer-review
Open access
Sustainable Development Goals
SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Article number
264Journal (Volume, Issue Number)
Signal Transduction and Targeted Therapy (Volume 5, Issue 1)Publication milestones
- Published - 12/2020
Publication status
Published - 12/2020
ISSN
2095-9907Publication IDs
- Scopus: 85095818083
- PubMed: 33173037
- ORCID: /0000-0002-0719-5862/work/89923701
Publication metrics
Metrics
SciVal
Author count
2
SciVal
Paper percentile
50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
8
Captures
17
Funding Details
Funding provided to HK by Georgia Cancer Center startup fund, American Cancer Society Intitutional pilot research fund, Bridge Fund by Augusta University Research Inc., Evans County CARES fund and Forbes Institute fund.
FundersFunding numbers
Augusta University Research Inc.
-Forbes Institute
-Georgia Cancer Center Breast Cancer Research Awards
-ACS
-